Drugs / D309
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04673682 | Nov 2020 → May 2022 | hypogonadism | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D309 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04673682 ↗ |
| Known as | Testosterone | “D309(Testosterone) 1 vial, Once, IM injection” NCT04673682 ↗ |
| Route | Intramuscular | “D309(Testosterone) 1 vial, Once, IM injection” NCT04673682 ↗ |